Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 560404, 11 pages
http://dx.doi.org/10.1155/2015/560404
Research Article

In Vitro and In Vivo Anticancer Activity of Root Extracts of Sansevieria liberica Gerome and Labroy (Agavaceae)

1Cancer Pharmacology Division, Indian Institute of Integrative Medicine (Council of Scientific & Industrial Research), Jammu 180001, India
2Department of Pharmacology, Therapeutics & Toxicology (PTT), Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, PMB 12003, Lagos 23401, Nigeria
3Natural Products Chemistry Division, Indian Institute of Integrative Medicine (Council of Scientific & Industrial Research), Jammu 180001, India

Received 6 January 2015; Accepted 8 February 2015

Academic Editor: Shrikant Anant

Copyright © 2015 Abidemi J. Akindele et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. P. Rao, U. R. Adagale, A. Shetty, P. Namjoshi, P. Gaitonde, and P. Jain, Cancer Immunotherapy, 2007, http://www.pharmainfo.net/reviews/cancer-immunotherapy.
  2. M. Mubeen and S. G. Kini, “A review on the design and development of EGFR tyrosine kinase inhibitors in cancer therapy,” International Journal of Therapeutic Applications, vol. 5, pp. 29–37, 2012. View at Google Scholar
  3. S. U. Park, “Anticancer compounds from plants,” EXCLI Journal, vol. 11, pp. 386–389, 2012. View at Google Scholar · View at Scopus
  4. World Health Organization (WHO), The Global Burden of Disease: 2004 Update, WHO, Geneva, Switzerland, 2008.
  5. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. C. J. Murray and A. Lopez, The Global Burden of Disease, Harvard University Press, Cambridge, UK, 1996.
  7. United Nations Development Programme (UNDP), Human Development Report 2000, Oxford University Press, Oxford, UK, 2000.
  8. G. Schwartsmann, M. J. Ratain, G. M. Cragg et al., “Anticancer drug discovery and development throughout the world,” Journal of Clinical Oncology, vol. 20, no. 18, pp. 47s–59s, 2002. View at Google Scholar · View at Scopus
  9. A. Goldin, P. V. Woolley, K. D. Tew, and P. S. Schein, “Sources of agents and their selection for antitumor activity screening,” in Anticancer Drug Development, P. Hilgard and K. Hellman, Eds., pp. 9–45, Prous, Barcelona, Spain, 1983. View at Google Scholar
  10. A. M. Burger and H.-H. Fiebig, “Preclinical screening for new anticancer agents,” in Handbook of Anticancer Pharmacokinetics and Pharmacodynamics, W. D. Figg and H. L. McLeod, Eds., pp. 29–44, Humana Press, New York, NY, USA, 2004. View at Google Scholar
  11. G. M. Cragg and D. J. Newman, “Medicinals for the millennia: the historical record,” Annals of the New York Academy of Sciences, vol. 953, pp. 3–25, 2001. View at Google Scholar · View at Scopus
  12. D. J. Newman, G. M. Cragg, and K. M. Snader, “The influence of natural products upon drug discovery,” Natural Product Reports, vol. 17, no. 3, pp. 219–220, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Watt and M. J. Breyer-Brandwiijk, Medicinal and Poisonous Plants of South and Eastern Africa, Churchill Livingstone, 2nd edition, 1962.
  14. H. M. Burkill, The Useful Plants of West Tropical Africa, vol. 3, 1985.
  15. J. Bero, V. Hannaert, G. Chataigné, M.-F. Hérent, and J. Quetin-Leclercq, “In vitro antitrypanosomal and antileishmanial activity of plants used in Benin in traditional medicine and bio-guided fractionation of the most active extract,” Journal of Ethnopharmacology, vol. 137, no. 2, pp. 998–1002, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. O. O. Adeyemi, A. J. Akindele, and E. A. Ogunleye, “Evaluation of the antidiarrhoeal effect of Sanseviera liberica Gerome & Labroy (Agavaceae) root extract,” Journal of Ethnopharmacology, vol. 123, no. 3, pp. 459–463, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Ikewuchi, C. C. Ikewuchi, N. M. Igboh, and T. Mark-Balm, “Protective effect of aqueous extract of the rhizomes of Sansevieria liberica gérôme and labroy on carbon tetrachloride induced hepatotoxicity in rats,” EXCLI Journal, vol. 10, pp. 312–321, 2011. View at Google Scholar · View at Scopus
  18. O. O. Adeyemi, O. K. Yemitan, and O. O. Adebiyi, “Sedative and anticonvulsant activities of the aqueous root extract of Sanseviera liberica Gerome & Labroy (Agavaceae),” Journal of Ethnopharmacology, vol. 113, no. 1, pp. 111–114, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Umukoro and R. B. Ashorobi, “Effects of the methanol leaf extract of Sansevieria liberica on the central nervous system in mice,” Journal of Natural Remedies, vol. 8, no. 2, pp. 242–246, 2008. View at Google Scholar · View at Scopus
  20. E. C. Chinasa, I.-A. S. Ifeoma, E. C. Obodoike, and E. S. Chhukwuemeka, “Evaluation of anti-inflammatory property of the leaves of Sansevieria liberica ger. and labr. (fam: Dracaenaceae),” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 10, pp. 791–795, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Bero, H. Ganfon, M.-C. Jonville et al., “In vitro antiplasmodial activity of plants used in Benin in traditional medicine to treat malaria,” Journal of Ethnopharmacology, vol. 122, no. 3, pp. 439–444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Rakoff-Nahoum, “Why cancer and inflammation?” Yale Journal of Biology and Medicine, vol. 79, no. 3-4, pp. 123–130, 2006. View at Google Scholar · View at Scopus
  23. B. B. Aggarwal, S. Shishodia, S. K. Sandur, M. K. Pandey, and G. Sethi, “Inflammation and cancer: how hot is the link?” Biochemical Pharmacology, vol. 72, no. 11, pp. 1605–1621, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. B. B. Aggarwal and S. Shishodia, “Molecular targets of dietary agents for prevention and therapy of cancer,” Biochemical Pharmacology, vol. 71, no. 10, pp. 1397–1421, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. M. B. Amida, O. K. Yemitan, and O. O. Adeyemi, “Toxicological assessment of the aqueous root extract of Sanseviera liberica Gerome and Labroy (Agavaceae),” Journal of Ethnopharmacology, vol. 113, no. 1, pp. 171–175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Samanta, A. Pain, S. Dutta et al., “Antitumor activity of nitronaphthal-NU, a novel mixed—function agent,” Journal of Experimental Therapeutics and Oncology, vol. 5, no. 1, pp. 15–22, 2005. View at Google Scholar · View at Scopus
  27. P. R. Sharma, D. M. Mondhe, S. Muthiah et al., “Anticancer activity of an essential oil from Cymbopogon flexuosus,” Chemico-Biological Interactions, vol. 179, no. 2-3, pp. 160–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Skehan, R. Storeng, D. Scudiero et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Monks, D. Scudiero, P. Skehan et al., “Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines,” Journal of the National Cancer Institute, vol. 83, no. 11, pp. 757–766, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Chashoo, S. K. Singh, P. R. Sharma et al., “A propionyloxy derivative of 11-keto-β-boswellic acid induces apoptosis in HL-60 cells mediated through topoisomerase i & II inhibition,” Chemico-Biological Interactions, vol. 189, no. 1-2, pp. 60–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. R. I. Geran, N. H. Greenberg, M. M. MacDonald, A. M. Schumacher, and B. J. Abbott, “Protocols for screening chemical agents and natural products against animal tumors and other biological systems,” Cancer Chemotherapy Reports, vol. 3, pp. 1–103, 1972. View at Google Scholar
  32. F. Malik, A. Kumar, S. Bhushan et al., “Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera,” European Journal of Cancer, vol. 45, no. 8, pp. 1494–1509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Todorova, M. Ilarionova, K. Todorov, and D. Todorov, “Antileukemic activity of epirubicin conjugated with biopolymer dextran against lymphoid leukemia L1210 as tumor model,” Biotechnology and Biotechnological Equipment, vol. 18, no. 2, pp. 128–130, 2004. View at Google Scholar · View at Scopus
  34. R. A. Mothana, U. Lindequist, R. Gruenert, and P. J. Bednarski, “Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra,” BMC Complementary and Alternative Medicine, vol. 9, article 7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Martin-Cordero, A. J. Leon-Gonzalez, J. M. Calderon-Montano, E. Burgos-Moron, and M. Lopez-Lazaro, “Pro-oxidant natural products as anticancer agents,” Current Drug Targets, vol. 13, no. 8, pp. 1006–1028, 2012. View at Publisher · View at Google Scholar
  36. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Denny and H. Wansbrough, “The design and development of anti-cancer drugs,” XII-Biotech-J-Cancer Drugs, pp. 1–12, 1995. View at Google Scholar
  38. K. Kam, “What is Integrative Medicine? Experts explore new ways to treat the mind, body, and spirit—all at the same time,” 2009, http://www.webmd.com/a-to-z-guides/features/alternative-medicine-integrative-medicine.
  39. C. Lammersfeld, “Integrative medicine: a team approach to cancer treatment,” 2014, http://www.cancercenter.com/discussions/blog/integrative-medicine-a-team-approach-to-cancer-treatment/.
  40. G. M. Marchetti, K. A. Silva, A. N. Santos et al., “The anticancer activity of dichloromethane crude extract obtained from Calea pinnatifida,” Journal of Experimental Pharmacology, vol. 4, pp. 157–162, 2012. View at Publisher · View at Google Scholar
  41. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the 30 years from 1981 to 2010,” Journal of Natural Products, vol. 75, no. 3, pp. 311–335, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. G. M. Cragg and D. J. Newman, “Nature: a vital source of leads for anticancer drug development,” Phytochemistry Reviews, vol. 8, no. 2, pp. 313–331, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. F. R. F. Nascimento, G. V. B. Cruz, P. V. S. Pereira et al., “Ascitic and solid Ehrlich tumor inhibition by Chenopodium ambrosioides L. treatment,” Life Sciences, vol. 78, no. 22, pp. 2650–2653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. M. K. Rates, “Plants as source of drugs,” Toxicon, vol. 39, no. 5, pp. 603–613, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. G. R. Waller and K. Yamasaki, Saponins Used in Traditional and Modern Medicine, Plenum Press, New York, NY, USA, 1996.
  47. Y. Mimaki, M. Kuroda, A. Yokosuka, and Y. Sashida, “Steroidal saponins from aerial parts of Sansevieria cylindrica,” Natural Medicines, vol. 52, article 374, 1998. View at Google Scholar · View at Scopus
  48. P. K. Haldar, B. Kar, A. Bala, S. Bhattacharya, and U. K. Mazumder, “Antitumor activity of Sansevieria roxburghiana rhizome against Ehrlich ascites carcinoma in mice,” Pharmaceutical Biology, vol. 48, no. 12, pp. 1337–1343, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Philip, P. K. Kaleena, and K. Valivittan, “In-vitro cytotoxicity and anticancer activity of Sansevieria roxburghiana,” International Journal of Current Pharmaceutical Research, vol. 3, no. 3, pp. 71–73, 2011. View at Google Scholar
  50. G. R. Pettit, Q. Zhang, V. Pinilla et al., “Antineoplastic agents. 534. Isolation and structure of sansevistatins 1 and 2 from the African Sansevieria ehrenbergii,” Journal of Natural Products, vol. 68, no. 5, pp. 729–733, 2005. View at Publisher · View at Google Scholar · View at Scopus